Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 055980/0056 | |
| Pages: | 7 |
| | Recorded: | 04/20/2021 | | |
| Attorney Dkt #: | 026156-8033 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17071121
|
Filing Dt:
|
10/15/2020
|
|
Publication #:
|
|
Pub Dt:
|
03/18/2021
| | | | |
|
Title:
|
CANCER THERAPY USING CLDN6 TARGET-DIRECTED ANTIBODIES IN VIVO
|
|
|
Assignees
|
|
|
|
|
| AN DER GOLDGRUBE 12 |
| MAINZ, GERMANY 55131 |
|
|
|
|
|
| SAARSTRASSE 21 |
| MAINZ, GERMANY 55122 |
|
|
Correspondence name and address
|
| |
KEVIN A. O'CONNOR
|
| |
2 NORTH LASALLE STREET, SUITE 1700
|
| |
NEAL, GERBER & EISENBERG LLP
|
| |
CHICAGO, IL 60602
|
Search Results as of:
09/22/2024 09:59 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
